Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.332,67
-0,40%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ uniQure NV (QURE) uniQure NV (QURE) Notizie

uniQure NV

QURE
14,00
-1,92 (-12,06%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/1/202522:25EDGAR2Form 8-K - Current report
08/1/202522:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/1/202513:05GLOBEuniQure Announces Pricing of its Public Offering
07/1/202523:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/1/202522:49GLOBEuniQure Announces Proposed Public Offering
07/1/202522:42EDGAR2Form S-3ASR - Automatic shelf registration statement of..
10/12/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:33EDGAR2Form 144 - Report of proposed sale of securities
10/12/202413:22EDGAR2Form 8-K - Current report
10/12/202413:05GLOBEuniQure Announces Alignment with FDA on Key Elements of..
21/11/202415:00EDGAR2Form 8-K - Current report
21/11/202413:05GLOBEuniQure Announces Dosing of First Patient in GenTLE Phase..
14/11/202418:01EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
05/11/202415:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202414:02EDGAR2Form 8-K - Current report
05/11/202413:05GLOBEuniQure Announces Third Quarter 2024 Financial Results and..
26/10/202403:48EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
15/10/202413:49EDGAR2Form 8-K - Current report
15/10/202413:05GLOBEuniQure Announces Dosing of First Patient in Phase I/II..
23/9/202413:35EDGAR2Form 8-K - Current report
23/9/202413:05GLOBEuniQure Announces Orphan Drug Designation Granted to AMT-191..
15/8/202413:48EDGAR2Form 8-K - Current report
15/8/202413:05GLOBEuniQure Announces Dosing of First Patient in Phase I/IIa..
01/8/202414:54EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/8/202413:51EDGAR2Form 8-K - Current report
01/8/202413:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202413:05GLOBEuniQure Announces Second Quarter 2024 Financial Results and..
23/7/202413:10EDGAR2Form 8-K - Current report
23/7/202413:05GLOBEuniQure Announces Closing of Sale of Manufacturing Facility..
09/7/202413:13EDGAR2Form 8-K - Current report
09/7/202413:05GLOBEuniQure Announces Positive Interim Data Update Demonstrating..
01/7/202413:05GLOBEuniQure Announces Sale of Commercial Manufacturing Facility..
20/6/202414:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/6/202414:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/6/202412:00EDGAR2Form 8-K - Current report
18/6/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202401:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202413:18EDGAR2Form 8-K - Current report
03/6/202413:05GLOBEuniQure Receives FDA Regenerative Medicine Advanced Therapy..
07/5/202414:03EDGAR2Form 8-K - Current report
07/5/202413:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:05GLOBEuniQure Announces First Quarter 2024 Financial Results and..
05/3/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 16,00 Min: 13,80 Max: 16,08
Chiusura: 15,92

La tua Cronologia

NASDAQ
QURE
uniQure NV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network